Avalo Therapeutics, Inc. (AVTX)
14.46
+0.54
(+3.88%)
USD |
NASDAQ |
Apr 27, 16:00
14.46
0.00 (0.00%)
After-Hours: 20:00
Avalo Therapeutics EPS Diluted (TTM) : -6.096 for Dec. 31, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.684 |
| AbbVie, Inc. | 2.361 |
| Relmada Therapeutics, Inc. | -1.470 |
| Theravance Biopharma, Inc. | 2.028 |
| Corcept Therapeutics, Inc. | 0.8181 |